Literature DB >> 7291106

Cerebral lupus erythematosus responding to plasmaphaeresis.

D T Evans, M Giles, D J Horne, A J d'Apice, A Riglar, B H Toh.   

Abstract

A 44-year-old nurse with a 12-year history of systemic lupus erythematosus developed a schizophrenia-like psychosis due to cerebral lupus. Prednisolone in doses up to 200 mg daily was ineffective. Levels of immune complexes by the Raji cell assay were greatly increased in serum and cerebrospinal fluid. Plasma exchange was performed on 4 occasions over 4 days. Three days later, there was a marked and sustained improvement in the mental state, the psychosis resolved and tests of psychological function and electroencephalographic abnormalities improved. There was a corresponding decrease in levels of immune complexes and in titres of anti-neuronal antibody. Five months later, several serological indices had risen to pre-plasmaphaeresis levels except for the level of immune complexes. The patient remained in clinical remission. This case provides further evidence that high levels of circulating immune complexes may be a determinant of cerebral lupus and that plasmaphaeresis may be of lasting benefit in this disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7291106      PMCID: PMC2424992          DOI: 10.1136/pgmj.57.666.247

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  9 in total

1.  Treatment of lupus nephritis.

Authors:  J V Donadio
Journal:  Nephron       Date:  1977       Impact factor: 2.847

2.  The choroid plexus in systemic lupus erythematosus.

Authors:  C J Atkins; J J Kondon; F P Quismorio; G J Friou
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

3.  Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.

Authors:  J B Winfield; C M Brunner; D Koffler
Journal:  Arthritis Rheum       Date:  1978-04

4.  Effect of plasma exchange on circulating immune complexes and antibody formation in patients treated with cyclophosphamide and prednisone.

Authors:  R D Rossen; E M Hersh; J T Sharp; K B McCredie; F Gyorkey; W N Suki; G Eknoyan; M A Reisberg
Journal:  Am J Med       Date:  1977-11       Impact factor: 4.965

5.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

6.  Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus.

Authors:  H A Wilson; J B Winfield; R G Lahita; D Koffler
Journal:  Arthritis Rheum       Date:  1979-05

7.  Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors:  U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

8.  Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.

Authors:  H G Bluestein
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

9.  Passive transfer of autoimmune disease with isologous IgG1 and IgG2 antibodies to the tubular basement membrane in strain XIII guinea pigs: loss of self-tolerance induced by autoantibodies.

Authors:  C L Hall; R B Colvin; K Carey; R T McCluskey
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Acute autonomic neuropathy in association with systemic lupus erythematosus.

Authors:  C Hoyle; D J Ewing; A C Parker
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

Review 2.  Therapeutic apheresis in autoimmune diseases.

Authors:  Rolf Bambauer; Reinhard Latza; Carolin Bambauer; Daniel Burgard; Ralf Schiel
Journal:  Open Access Rheumatol       Date:  2013-11-13

Review 3.  Application of Plasma Exchange in Steroid-Responsive Encephalopathy.

Authors:  Yuting Jiang; Xin Tian; Yixue Gu; Feng Li; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.